Delivery Order SPE2DB20D2014-SPE2DB24FC75K

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,720.66 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TRELEGY ELLIPTA 100-62.5-25 60S medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceutical products and medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,631.55 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through July 3, 2024, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
The U.S. Defense Logistics Agency (DLA) awarded a $12,151.24 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,683,732 units of the drug TRELEGY ELLIPTA 200-62.5-25 60S. The contract has a completion date of September 5, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $12,193.62 firm fixed price contract has an ultimate completion date of April 23, 2024 and is not set aside for any small business designation. Amerisourcebergen is fulfilling this order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a $84,684.99 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication, which is a respiratory treatment product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a wide range of pharmaceutical and...
This is a $21,548.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S medication. The contract is not set aside and has an ultimate completion date of May 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The $52,206.41 firm fixed price contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which allows...
The U.S. government has awarded a Delivery Order contract valued at $20,600.23 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60S medication. The contract is administered by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for supplying medical products to federal agencies. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,679.80 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a $12,708.92 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency Troop Support Medical. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support military healthcare programs. The contract has an ultimate completion date of January 22, 2024 and was awarded on January 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC75K
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $36,100.70 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRELEGY ELLIPTA 200-62.5-25 60S respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for supplying a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is intended to deliver the respiratory medication by August 15, 2024.

Generated 11/13/24, 9:18 AM